The Ala variant of this polymorphism has been consistently associated with prostate cancer risk and increased aggressiveness either alone or when the antioxidant intake is low [11,14,35,36,37], indicating that higher levels of SOD2 activity might help prostate cancer progression similarly to our results obtained in a study of a cohort of patients [12]. Here, SOD2 is linked to prostate carcinoma.